{"id":2044,"date":"2019-10-03T11:27:10","date_gmt":"2019-10-03T15:27:10","guid":{"rendered":"https:\/\/med.virginia.edu\/bims\/?p=2044"},"modified":"2026-05-01T13:06:06","modified_gmt":"2026-05-01T17:06:06","slug":"uva-professors-promising-cancer-drug-attracts-25-million-in-funding","status":"publish","type":"post","link":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/","title":{"rendered":"UVA Professor\u2019s Promising Cancer Drug Attracts $25 Million in Funding"},"content":{"rendered":"

\"Kim<\/p>\n

UVA biomedical engineering professor Kimberly Kelly founded ZielBio to bring new cancer treatments to market. (Photo by Dan Addison, University Communications)
\n<\/span><\/p>\n

I<\/span>n her previous post as an assistant professor at Massachusetts General Hospital, University of Virginia biomedical engineering professor Kimberly Kelly discovered something unusual about cancer cells. Many of them have plectin \u2013 a protein normally found in cells\u2019 interior cytoskeletons\u2013 on their surface.<\/p>\n

\u201cWe don\u2019t know how plectin gets on the surface of cancer cells, but we do know that it is necessary for the cancer to grow and metastasize,\u201d said Kelly.<\/p>\n

That, of course, makes it a prime target for researchers, like Kelly, who are searching for a cure. And, it\u2019s a big reason that the Charlottesville-based biotechnology company she founded, ZielBio, closed an extraordinary $25.1 million in Series A financing late last month.<\/p>\n

More info in UVA Today, 10\/2\/19<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

UVA biomedical engineering professor Kimberly Kelly founded ZielBio to bring new cancer treatments to market. (Photo by Dan Addison, University Communications) In her previous post as an assistant professor at Massachusetts General Hospital, University of Virginia biomedical engineering professor Kimberly Kelly discovered something unusual about cancer cells. Many of them have plectin \u2013 a protein […]<\/p>\n","protected":false},"author":710,"featured_media":2043,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[4],"tags":[26],"class_list":["post-2044","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-highlights","tag-delete"],"acf":false,"yoast_head":"\nUVA Professor\u2019s Promising Cancer Drug Attracts $25 Million in Funding - Biomedical Sciences Graduate Program<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UVA Professor\u2019s Promising Cancer Drug Attracts $25 Million in Funding - Biomedical Sciences Graduate Program\" \/>\n<meta property=\"og:description\" content=\"UVA biomedical engineering professor Kimberly Kelly founded ZielBio to bring new cancer treatments to market. (Photo by Dan Addison, University Communications) In her previous post as an assistant professor at Massachusetts General Hospital, University of Virginia biomedical engineering professor Kimberly Kelly discovered something unusual about cancer cells. Many of them have plectin \u2013 a protein […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Biomedical Sciences Graduate Program\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-03T15:27:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-01T17:06:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2019\/10\/Kim-Kelly_smsq.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"250\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ajh6a@virginia.edu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ajh6a@virginia.edu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/\"},\"author\":{\"name\":\"ajh6a@virginia.edu\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/#\\\/schema\\\/person\\\/431cdd87cdf93b8d4ef9709b0c1b8567\"},\"headline\":\"UVA Professor\u2019s Promising Cancer Drug Attracts $25 Million in Funding\",\"datePublished\":\"2019-10-03T15:27:10+00:00\",\"dateModified\":\"2026-05-01T17:06:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/\"},\"wordCount\":151,\"image\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/wp-content\\\/uploads\\\/sites\\\/390\\\/2019\\\/10\\\/Kim-Kelly_smsq.jpg\",\"keywords\":[\"Delete\"],\"articleSection\":[\"Research Highlights\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/\",\"url\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/\",\"name\":\"UVA Professor\u2019s Promising Cancer Drug Attracts $25 Million in Funding - Biomedical Sciences Graduate Program\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/wp-content\\\/uploads\\\/sites\\\/390\\\/2019\\\/10\\\/Kim-Kelly_smsq.jpg\",\"datePublished\":\"2019-10-03T15:27:10+00:00\",\"dateModified\":\"2026-05-01T17:06:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/#\\\/schema\\\/person\\\/431cdd87cdf93b8d4ef9709b0c1b8567\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/#primaryimage\",\"url\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/wp-content\\\/uploads\\\/sites\\\/390\\\/2019\\\/10\\\/Kim-Kelly_smsq.jpg\",\"contentUrl\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/wp-content\\\/uploads\\\/sites\\\/390\\\/2019\\\/10\\\/Kim-Kelly_smsq.jpg\",\"width\":250,\"height\":250,\"caption\":\"Kim Kelly\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UVA Professor\u2019s Promising Cancer Drug Attracts $25 Million in Funding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/#website\",\"url\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/\",\"name\":\"Biomedical Sciences Graduate Program\",\"description\":\"University of Virginia School of Medicine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/#\\\/schema\\\/person\\\/431cdd87cdf93b8d4ef9709b0c1b8567\",\"name\":\"ajh6a@virginia.edu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ac244977a9757ab1b4b0045efad7473d771b10db3312fbe2956c234fac75d28?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ac244977a9757ab1b4b0045efad7473d771b10db3312fbe2956c234fac75d28?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ac244977a9757ab1b4b0045efad7473d771b10db3312fbe2956c234fac75d28?s=96&d=mm&r=g\",\"caption\":\"ajh6a@virginia.edu\"},\"url\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/author\\\/ajh6avirginia-edu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UVA Professor\u2019s Promising Cancer Drug Attracts $25 Million in Funding - Biomedical Sciences Graduate Program","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/","og_locale":"en_US","og_type":"article","og_title":"UVA Professor\u2019s Promising Cancer Drug Attracts $25 Million in Funding - Biomedical Sciences Graduate Program","og_description":"UVA biomedical engineering professor Kimberly Kelly founded ZielBio to bring new cancer treatments to market. (Photo by Dan Addison, University Communications) In her previous post as an assistant professor at Massachusetts General Hospital, University of Virginia biomedical engineering professor Kimberly Kelly discovered something unusual about cancer cells. Many of them have plectin \u2013 a protein […]","og_url":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/","og_site_name":"Biomedical Sciences Graduate Program","article_published_time":"2019-10-03T15:27:10+00:00","article_modified_time":"2026-05-01T17:06:06+00:00","og_image":[{"width":250,"height":250,"url":"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2019\/10\/Kim-Kelly_smsq.jpg","type":"image\/jpeg"}],"author":"ajh6a@virginia.edu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ajh6a@virginia.edu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/#article","isPartOf":{"@id":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/"},"author":{"name":"ajh6a@virginia.edu","@id":"https:\/\/med.virginia.edu\/bims\/#\/schema\/person\/431cdd87cdf93b8d4ef9709b0c1b8567"},"headline":"UVA Professor\u2019s Promising Cancer Drug Attracts $25 Million in Funding","datePublished":"2019-10-03T15:27:10+00:00","dateModified":"2026-05-01T17:06:06+00:00","mainEntityOfPage":{"@id":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/"},"wordCount":151,"image":{"@id":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2019\/10\/Kim-Kelly_smsq.jpg","keywords":["Delete"],"articleSection":["Research Highlights"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/","url":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/","name":"UVA Professor\u2019s Promising Cancer Drug Attracts $25 Million in Funding - Biomedical Sciences Graduate Program","isPartOf":{"@id":"https:\/\/med.virginia.edu\/bims\/#website"},"primaryImageOfPage":{"@id":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/#primaryimage"},"image":{"@id":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2019\/10\/Kim-Kelly_smsq.jpg","datePublished":"2019-10-03T15:27:10+00:00","dateModified":"2026-05-01T17:06:06+00:00","author":{"@id":"https:\/\/med.virginia.edu\/bims\/#\/schema\/person\/431cdd87cdf93b8d4ef9709b0c1b8567"},"breadcrumb":{"@id":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/#primaryimage","url":"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2019\/10\/Kim-Kelly_smsq.jpg","contentUrl":"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2019\/10\/Kim-Kelly_smsq.jpg","width":250,"height":250,"caption":"Kim Kelly"},{"@type":"BreadcrumbList","@id":"https:\/\/med.virginia.edu\/bims\/uva-professors-promising-cancer-drug-attracts-25-million-in-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/med.virginia.edu\/bims\/"},{"@type":"ListItem","position":2,"name":"UVA Professor\u2019s Promising Cancer Drug Attracts $25 Million in Funding"}]},{"@type":"WebSite","@id":"https:\/\/med.virginia.edu\/bims\/#website","url":"https:\/\/med.virginia.edu\/bims\/","name":"Biomedical Sciences Graduate Program","description":"University of Virginia School of Medicine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/med.virginia.edu\/bims\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/med.virginia.edu\/bims\/#\/schema\/person\/431cdd87cdf93b8d4ef9709b0c1b8567","name":"ajh6a@virginia.edu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1ac244977a9757ab1b4b0045efad7473d771b10db3312fbe2956c234fac75d28?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1ac244977a9757ab1b4b0045efad7473d771b10db3312fbe2956c234fac75d28?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ac244977a9757ab1b4b0045efad7473d771b10db3312fbe2956c234fac75d28?s=96&d=mm&r=g","caption":"ajh6a@virginia.edu"},"url":"https:\/\/med.virginia.edu\/bims\/author\/ajh6avirginia-edu\/"}]}},"_links":{"self":[{"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/posts\/2044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/users\/710"}],"replies":[{"embeddable":true,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/comments?post=2044"}],"version-history":[{"count":5,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/posts\/2044\/revisions"}],"predecessor-version":[{"id":5459,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/posts\/2044\/revisions\/5459"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/media\/2043"}],"wp:attachment":[{"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/media?parent=2044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/categories?post=2044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/tags?post=2044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}